Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
Nature Communications|September 26, 2014
Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancerColin C Pritchard, Colm Morrissey, Akash Kumar, et al.
The Journal of Clinical Investigation|July 17, 2019
Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damagePayel Chatterjee, Michael T Schweizer, Jared M Lucas, et al.
Plos One|September 9, 2014
Chemotherapy-induced monoamine oxidase expression in prostate carcinoma functions as a cytoprotective resistance enzyme and associates with clinical outcomesRyan R Gordon, Mengchu Wu, Chung-Ying Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2016
Characterization of an Abiraterone Ultraresponsive Phenotype in Castration-Resistant Prostate Cancer Patient-Derived XenograftsHung-Ming Lam, Ryan McMullin, Holly M Nguyen, et al.
The Journal of Clinical Investigation|September 16, 2025
Multiomic assessments of LNCaP and derived cell strains reveal determinants of prostate cancer pathobiologyArnab Bose, Armand Bankhead, Ilsa Coleman, et al.
Oncogene|September 29, 2020
Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitorsYezi Zhu, Susan L Dalrymple, Ilsa Coleman, et al.
The EMBO Journal|February 7, 2019
EZH2 cooperates with gain-of-function p53 mutants to promote cancer growth and metastasisYu Zhao, Liya Ding, Dejie Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2019
Identification of Therapeutic Vulnerabilities in Small-cell Neuroendocrine Prostate CancerAlexandra N Corella, Ma Victoria Andrea Cabiliza Ordonio, Ilsa Coleman, et al.
Molecular Oncology|February 2, 2017
Gene expression panel predicts metastatic-lethal prostate cancer outcomes in men diagnosed with clinically localized prostate cancerRohina Rubicz, Shanshan Zhao, Jonathan L Wright, et al.
The Prostate|March 19, 2016
Characterizing the molecular features of ERG-positive tumors in primary and castration resistant prostate cancerMartine P Roudier, Brian R Winters, Ilsa Coleman, et al.
Pageof 10